Overview

Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma

Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of liver-localised radioembolization and nivolumab on liver cancer.
Phase:
Phase 2
Details
Lead Sponsor:
National Cancer Centre, Singapore
Treatments:
Antibodies, Monoclonal
Nivolumab